Globus Starts Slow But Reaffirms Guidance for 2022

Globus Medical reported 1Q22 orthopedic sales of $230.5 million, +1.4% compared to 1Q21.

The modest growth resulted from COVID headwinds, a difficult prior-year comparison and a slow-developing capital sales pipeline. Globus leaders said hospitals shifted focus to managing COVID cases and staffing shortages. Despite the temporary sales...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us